AI assistant
PEAK PROCESSING LIMITED — Regulatory Filings 2020
Sep 13, 2020
65568_rns_2020-09-13_e2936949-7afd-4c55-92d6-0b502912ca96.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [595 x 148] intentionally omitted <==
ASX Announcement | 14 September 2020 Althea Group Holdings (ASX:AGH)
Notice of Release from Escrow
In accordance with ASX Listing Rule 3.10A, Althea Group Holdings (ASX:AGH) advises that that the following securities are due to be released from escrow on 21 September 2020.
| Security Description | Name of Holder | Number of Securities |
|---|---|---|
| OrdinaryShares | Joshua Fegan | 56,250,000 |
| OrdinaryShares | Aphria Inc | 12,250,000 |
| OrdinaryShares | Mancann Holdings | 10,000,000 |
| OrdinaryShares | PAC Partners | 3,090,361 |
| TOTAL | 81,590,361 |
Althea’s shareholders continue to support the company and have provided the below statements confirming their ongoing belief and commitment to maintaining their interests in Althea.
Althea CEO Joshua Fegan said : “As Althea’s CEO and largest shareholder, I remain firmly committed to retaining my stake in the company and further advancing our global business. We have big things planned for FY21 and continue to make significant progress across our operations which now span Australia, the UK, Canada and Germany.”
Aphria Inc CEO Irwin Simon said: “We continue to maintain a sizable 5% ownership stake in Althea. We remain impressed with the vision and strategy developed by Josh and are pleased with the progress executing on that plan. Our current product supply agreement was recently extended to 2027 demonstrating our commitment to our long-term relationship with Althea.”
Mancann Holdings Sole Director Daniel Mansfield said: “We are long-time supporters of Althea and its mission, having invested in the company since its IPO. We maintain our belief that Althea will succeed in becoming a major player in the global cannabis market and plan to maintain our large stake in the company for the foreseeable future.”
-ENDS-
Authorised by: Robert Meissner, Company Secretary
For further information, please contact:
Althea Media Enquiries Josh Fegan Dan Francome CEO & Managing Director Media Relations M: 1300 70 20 20 P: +613 9650 5096 E: [email protected] E: [email protected]
==> picture [595 x 92] intentionally omitted <==
==> picture [595 x 148] intentionally omitted <==
Althea Group Holdings Limited (ASX:AGH)
Althea Group Holdings Ltd (ASX:AGH) is a global pharmaceutical company and supplier of medicinal cannabis. Althea also offers a range of education, access and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways.
Althea currently operates within highly regulated medicinal cannabis markets including Australia, United Kingdom and Germany, with plans to expand into emerging markets throughout Asia and Europe.
To learn more, please visit: www.althea.life
==> picture [595 x 92] intentionally omitted <==